Detalles de la búsqueda
1.
All-cause, premature, and cardiovascular death attributable to socioeconomic and ethnic disparities among New Zealanders with type 1 diabetes 1994-2019: a multi-linked population-based cohort study.
BMC Public Health
; 24(1): 298, 2024 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38273238
2.
Long-term impact of type 2 diabetes onset on dementia incidence rate among New Zealanders with impaired glucose tolerance: A tapered-matched landmark analysis over 25 years.
Alzheimers Dement
; 2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38874317
3.
Effect of onset of type 2 diabetes on risks of cardiovascular disease and heart failure among new Zealanders with impaired glucose tolerance over 25 years: tapered-matched landmark analysis.
Cardiovasc Diabetol
; 22(1): 163, 2023 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391762
4.
Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study.
Lancet
; 397(10291): 2264-2274, 2021 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34089656
5.
Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study.
Ann Rheum Dis
; 73(5): 797-802, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24255548
6.
Uncovering Structural Plasticity of Enterovirus A through Deep Insertional and Deletional Scanning.
Res Sq
; 2024 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38410474
7.
Adverse Clinical Outcomes Attributable to Socioeconomic and Ethnic Disparities Among People with Type 2 Diabetes in New Zealand Between 1994-2018: A Multiple Linked Cohort Study.
Clin Epidemiol
; 15: 511-523, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37153075
8.
Health Inequality in Eight Adverse Outcomes Over a 25-Year Period in a Multi-Ethnic Population in New Zealand Population with Impaired Glucose Tolerance and/or Impaired Fasting Glucose: An Age-Period-Cohort Analysis.
Clin Epidemiol
; 15: 1123-1143, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38084129
9.
Association Between Onset of Type 2 Diabetes and Risk of Atrial Fibrillation in New Zealanders With Impaired Glucose Tolerance Over 25 Years.
J Am Heart Assoc
; 12(18): e030159, 2023 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37702092
10.
Does a diabetes annual review make a difference?
Diabet Med
; 29(8): e217-22, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22141458
11.
Are patients receiving recommended bone protection therapy after a non-hip fracture? A retrospective study of the Fracture Liaison Service at Counties Manukau District Health Board.
N Z Med J
; 135(1561): 15-21, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36049786
12.
Ethnic differences in metabolic achievement between Maori, Pacific, and European New Zealanders with type 2 diabetes.
Diabetes Res Clin Pract
; 189: 109910, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35537520
13.
Ethnic Differences in Cancer Rates Among Adults With Type 2 Diabetes in New Zealand From 1994 to 2018.
JAMA Netw Open
; 5(2): e2147171, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35129595
14.
Ethnic differences in 25-year risk of incident chronic kidney disease among people with type 2 diabetes in New Zealand.
BMJ Open Diabetes Res Care
; 10(6)2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36521879
15.
Stratified glucose-lowering response to vildagliptin and pioglitazone by obesity and hypertriglyceridemia in a randomized crossover trial.
Front Endocrinol (Lausanne)
; 13: 1091421, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36699039
16.
Ethnic differences in mortality and hospital admission rates between Maori, Pacific, and European New Zealanders with type 2 diabetes between 1994 and 2018: a retrospective, population-based, longitudinal cohort study.
Lancet Glob Health
; 9(2): e209-e217, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33069275
17.
Diabetic ketoacidosis admissions at Middlemore Hospital: observational study of cause and patient demographics.
N Z Med J
; 133(1525): 34-40, 2020 11 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33223546
18.
Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocol.
BMJ Open
; 10(9): e036518, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32873667
19.
Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial.
J Clin Endocrinol Metab
; 92(7): 2446-52, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17440020
20.
Thyrotoxic, hypokalaemic periodic paralysis: Polynesians, an ethnic group at risk.
Intern Med J
; 37(5): 303-7, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17504277